Association of minimal residual disease with clinical outcomes in Philadelphia chromosome positive acute lymphoblastic leukemia in the tyrosine kinase inhibitor era: A systemic literature review and meta-analysis

Minimal residual disease (MRD) appeared to be a potent prognostic indicator in patients with Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL), with potential value in informing individualized treatment decisions. Hence, we performed herein a systemic literature review and meta...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Wanhua, Jang, Erguai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8389458/
https://www.ncbi.nlm.nih.gov/pubmed/34437635
http://dx.doi.org/10.1371/journal.pone.0256801

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8389458/
https://www.ncbi.nlm.nih.gov/pubmed/34437635
http://dx.doi.org/10.1371/journal.pone.0256801

Ejemplares similares